antagonism
bortezomib
carboplatin
clinically
combinations
curve
cytotoxic
deacetylase
docetaxel
downregulated
doxorubicin
enhancement
exhibits
gemcitabine
markedly
metformin
multitude
overexpressing
pan
panobinostat
proteasome
survivin
synergism
synergistic
synergy
triplet
universal
utility
warranted
|